Bristol-Myers Squibb (BMY) Tops Q2 EPS by 1c; Raises FY11 Outlook
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $64.83 +1.77%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bristol-Myers Squibb Company (NYSE: BMY) reported Q2 EPS of $0.56, $0.01 better than the analyst estimate of $0.55. Revenue for the quarter came in at $5.4 billion versus the consensus estimate of $5.04 billion.
Sees FY2011 EPS of $2.20-$2.30, versus prior guidance of $2.10-$2.20 and the consensus of $2.21.
Sees FY2011 EPS of $2.20-$2.30, versus prior guidance of $2.10-$2.20 and the consensus of $2.21.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
- Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
